Q&A: New registry aims to report COVID-19 outcomes among IBD patients

As COVID-19 continues to spread, gastroenterologists are assessing how the virus impacts patients with inflammatory bowel disease.Recently the Surveillance Epidemiology of Coronavirus Under Research Exclusion-IBD (SECURE-IBD) registry was launched. This registry monitors and reports outcomes of COVID-19 in patients with IBD. The registry aims to answer questions patients with IBD and their caregivers may have.Healio Gastroenterology and Liver Disease spoke with Ryan C. Ungaro, MD, a gastroenterologist with Mount Sinai Hospital’s Feinstein IBD Center, about the SECURE-IBD registry andRead More

Share on facebook
Share on twitter
Share on linkedin